WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic def... WAVE Life Sciences Ltd is a preclinical biopharmaceutical company based in Singapore. It owns a diverse pipeline of nucleic acid therapeutics meant to address rare genetic diseases related to the central nervous system, muscles, eyes, liver, and skin. Its nucleic acid therapeutics target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. Show more
Designation highlights significant unmet needs in DMD; dystrophin data from potentially registrational FORWARD-53 trial of WVE-N531 are on track for 3Q 2024 In previous Part A trial, WVE-N531...
Successful clinical translation of Wave’s RNA medicines platform in HD patients with WVE-003 provides further validation of Wave’s proprietary platform with PN and stereochemistry; opt-in package...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.03 | -0.502512562814 | 5.97 | 6.03 | 5.47 | 478842 | 5.7960106 | CS |
4 | 0.08 | 1.36518771331 | 5.86 | 6.15 | 5.04 | 506669 | 5.67481234 | CS |
12 | 1.63 | 37.819025522 | 4.31 | 6.855 | 4.25 | 692449 | 5.71372384 | CS |
26 | 0.28 | 4.94699646643 | 5.66 | 6.855 | 4.25 | 732222 | 5.61680423 | CS |
52 | 0.9 | 17.8571428571 | 5.04 | 7.67 | 3.5 | 735479 | 5.41337968 | CS |
156 | 0.36 | 6.45161290323 | 5.58 | 7.67 | 1.16 | 541222 | 4.54250667 | CS |
260 | -19.74 | -76.8691588785 | 25.68 | 39.99 | 1.16 | 608793 | 7.03101847 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.